Medicament for treating acute pyogenic infection of skin

A technology of medicine and sores, which is applied in the field of medicines for the treatment of acute sores, can solve the problems of increasing patients' pain, complications, and low curative effect, and achieve the effects of no toxic side effects, low treatment costs, and high cure rate

Inactive Publication Date: 2008-10-29
李三猛
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Acute sores are a common disease, and the incidence rate has decreased compared with the 1960s and 1970s, but the incidence is still high in the old, young, border and poor areas. If it is not treated in time, it is very easy to cause evil poison invagination and concurrent critical illness. At present, Western medicine mostly uses anti-inflammatory drugs such as penicillin and cephalosporin as well as surgical methods for treatment. Due to the increase of drug resis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a drug for treating acute carbuncle, which is prepared by traditional Chinese medicine. The drug is characterized in that the drug comprises the main drugs with the following weights: 50 to 110g of humifuse euphorbia herb, 50 to 110g of willow twig, 30 to 70g of sun euphorbia herb, 30 to 70g of Chinese honeylocust spine, 50 to 120g of Szechwan chinaberry leaf and 2 to 7g of gadfly; the adjuvants with the following weights: 60 to 110g of leaf of trifoliate-orange and 50 to 110g of mulberry fruit; and the excipients with the following weights: 15 to 50g of Japanese thistle herb or root, 50 to 110g of peach leaf, 60 to 110g of twig of Japanese pagoda tree, 70 to 130g of Siberian elm bark, 40 to 80g of lactuca debilis and 40 to 80g of royal paulowinia flower. The whole formula has perfect compatibility, powerful drug efficacy and orderly sequence, which can hit the disease mechanism and fully reflect the treatment principles of clearing heat, removing toxin, detumescence, relieving pain, activating blood circulation, removing blood stasis, eliminating pus and promoting granulation.

Description

A drug for treating acute sores technical field The invention relates to a medicine for treating acute sores, in particular to an externally used medicine for treating sores made of Chinese herbal medicine. Background technique Acute sores are a common disease, and the incidence rate has decreased compared with the 1960s and 1970s, but the incidence is still high in the old, young, border and poor areas. If it is not treated in time, it is very easy to cause evil poison invagination and concurrent critical illness. At present, Western medicine mostly uses anti-inflammatory drugs such as penicillin and cephalosporin and surgical methods for treatment. Due to the increase of drug resistance of bacteria, the therapeutic effect of some anti-inflammatory drugs is getting weaker and weaker. Surgical treatment one is to increase the misery of patient, the other is to leave scar, influences attractive in appearance. Compared with Western medicine, external-use ointments of tradit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/58A61K36/75A61K36/80A61P17/02A61K35/64
Inventor 李三猛
Owner 李三猛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products